News
3T Biosciences Builds Transatlantic Pan-Cancer Research Pipeline to Target Most Difficult-to-Treat Cancers
Boehringer Ingelheim and 3T Biosciences enter into a second partnership to develop next-generation cancer immunotherapies
Publications
- 3T Platform & TCR Profiling
- Target Identification for Autoimmune Disease
- Target Identification for Oncology Indications
![PNAS logo](https://3tbiosciences.com/wp-content/uploads/2022/08/PNASlogo-edit.png)
Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro
Proceedings of the National Academy of Sciences (PNAS)
![Natchembio logo](https://3tbiosciences.com/wp-content/uploads/2022/08/NatchembioCMYK.jpg)
T cell receptor cross-reactivity expanded by dramatic peptide/MHC adaptability
Nature Chemical Biology
![Science Direct Logo](https://3tbiosciences.com/wp-content/uploads/2022/08/ScienceDirect_logo_2020.png)
Intracellular targets as source for cleaner targets for the treatment of solid tumors
Biochemical Pharmacology
![Spiral cells graphic](https://3tbiosciences.com/wp-content/uploads/2022/07/iStock-1362382022-v1.jpg)